Department of Health and Human Services October 8, 2010 – Federal Register Recent Federal Regulation Documents

The Administration for Children and Families (ACF), Office of Administration (OA), Office of Information Services (OIS) announces the award of a single-source cooperative agreement to the Johns Hopkins University (JHU), Applied Physics Lab (APL) and School of Public Health, in Baltimore, MD, to support the development of a Human Services National Interoperable Architecture. Under the award, APL will develop an architectural framework that will be used as a model to facilitate State and local agencies in information exchanges among eligibility and verification services that are developed by the HHS/ Centers for Medicare and Medicaid Services (CMS) under the requirements of the Patient Protection and Affordable Care Act (ACA). To address issues related to implementation of the ACA and the Improper Payments and Recovery Act of 2010, the Administration has directed Agencies to begin to design and execute plans related to the legislation. Under ACA, CMS has been directed to create a technical solution that enables health-related eligibility and enrollment functions and to ensure that the human services agencies can use the solutions for human services eligibility and verification determination. Under the Improper Payments and Recovery Act of 2010, Agencies must design and begin the execution of plans to eliminate improper payments and fraud. JHU will create the development of a conceptual information technology architecture with ACF/Office of Information Services. The project will produce a solution that supports information exchanges and interoperability that will lead to reductions in improper payments as a preventative step in the program integrity process.

The National Institutes of Health is announcing a public meeting to gather stakeholder perspectives on its plan to develop the Genetic Testing Registry. The meeting will provide a forum for interested stakeholders to provide comments on specific aspects of the plan. Date and Time: The public meeting will be held November 2, 2010, from 9 a.m. to 12 p.m. Location: The public meeting will be held at the Walter E. Johnson Convention Center, Room 147, 801 Mount Vernon Place, NW., Washington, DC 20001. For directions, please contact the Convention Center at 202- 249-3000 or refer to the following Web site: https:// www.dcconvention.com/. Special accommodations: Anyone planning to attend the meeting who needs special assistance, such as sign language interpretation or other reasonable accommodations, is asked to contact Cathy Fomous (see Contacts section) by October 26, 2010. Registration: If you wish to attend the public meeting, please register by October 27, 2010. Registration is free and on a first-come, first-served basis. Pre-registration can be completed online at https:// oba.od.nih.gov/gtr/gtrmeetings.html. Persons without Internet access may call Ms. Nicole Numbers at 301-650-8660. Onsite registration will be based on space availability. Requests for Oral Presentations: Interested persons who would like to make oral comments during the meeting will be given 5 minutes to do so if they submit their request by October 27, 2010, to Cathy Fomous. Send requests by e-mail to cfomous@od.nih.gov; by fax to 301-496-9839; or via postal service to Cathy Fomous, Ph.D., Office of Biotechnology Activities, National Institutes of Health, 6705 Rockledge Dr., Suite 750, Bethesda, MD 20892. The request should include the commenter's name, title, affiliation, address, e-mail address, and telephone number. All requests should indicate which questions outlined below in the section on Public Meeting Focus will be addressed. Depending on the number of individuals and organizations that submit requests to make oral remarks, the allotted time may be expanded or shortened to provide all interested parties an opportunity to present. Written Comments: Interested persons who cannot attend the meeting may submit written comments on the questions outlined below. Comments should be submitted to Cathy Fomous via e-mail, fax, or postal service using the above contact information. The comment period for written comments closes on November 12, 2010. Contacts: For questions about the meeting logistics, please contact Ms. Nicole Numbers at numbers@palladianpartners.com or 301-650-8660. For special accommodations or questions about the meeting agenda and public comments, please contact Cathy Fomous, Ph.D., NIH Office of Biotechnology Activities at cfomous@od.nih.gov or 301-496-9838.

Section 3003(b)(3) of the American Recovery and Reinvestment Act of 2009 mandates that the HIT Standards Committee develop a schedule for the assessment of policy recommendations developed by the HIT Policy Committee and publish it in the Federal Register. This notice fulfills the requirements of Section 3003(b)(3) and updates the schedule posted in the Federal Register on May 26, 2009. In anticipation of receiving recommendations originally developed by the HIT Policy Committee, the HIT Standards Committee has created four (4) workgroups or subcommittees to analyze the areas of clinical quality, clinical operations, implementation, and privacy and security.

The U.S. Department of Health and Human Services, in its role as the Chair of the Interagency Working Group on Youth Programs, is announcing a meeting to solicit input from the public that will inform the development of a strategic plan for federal youth policy.